Cyberounds Logo
January 18, 2020 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Targeting B cells in Systemic Lupus Erythematosus
CME credit is no longer available for this conference.
Liliane Min, M.D., Peter Barland, M.D., and Elena Peeva, M.D.

Dr. Min is a Fellow in Rheumatology and Dr. Peeva is Assistant Professor of Medicine, both at The Albert Einstein College of Medicine, New York.

Within the past 12 months, Dr. Peeva has received grant support from Immunomedics. Drs. Min and Barland report no commerical conflicts of interest.

Release Date: 03/20/2006
Termination Date: 03/20/2009

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the B cell-depleting therapies for SLE now undergoing clinical trials
  • Discuss the B cell-stimulating cytokines for SLE now undergoing clinical trials
  • Discuss the safety profile of the above treatments.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity